EN DE
Watch NanoenTekInc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

NanoenTekInc (039860) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of NanoenTekInc stock KRW 919, price KRW 3,980, that is 76.9% below the price, quality 49 out of 100. Rating: strongly overvalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Technology KR · ISIN KR7039860002

N NanoenTekInc logo Some data Nov 8, 2026

NanoenTekInc

039860 · KQ
Very expensive, weak quality

Our calculation puts a fair price 77% below what the stock costs today.

Solidly profitable · 13.3% net margin (TTM)
Low debt
Generates free cash flow
Revenue last quarter +39% vs. a year ago.
Quality 49/100
Mixed Growth (revenue 5y +5.3 %/yr in KRW)
Mixed vs. peers (7/13)
Some data
Fair value 918.64 KRW · Strongly overvalued
Narrow moat 39/100 · thin data
Watch NanoenTekInc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

9,700 KRW 2,785 KRW Fair Value 918.64 KRW Jun 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.

How to read this chart

60‑month range 2,785 KRW – 9,700 KRW · fair‑value band 688.98 KRW – 1,148 KRW · the 3,980 KRW price screens above the 918.64 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.

Follow NanoenTekInc in your weekly email

Every Wednesday you see whether NanoenTekInc is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally.

Show moreShow less

It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a residual white blood cell counters; ADAMII/fluorescence stem cell counter; fluorescence cell counters and cell analyzers; brightfield cell counters; somatic cell counters; live-cell imaging system; and disposable hemocytometers.

The company also provides digital healthcare services integrating artificial intelligence and big data technologies. The company was founded in 1987 and is headquartered in Seoul, South Korea.

Stock analysis

NanoenTekInc (039860) currently trades at 3,980 KRW, while our model-based Fair Value estimate is 918.64 KRW, 77% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Asset-Based group reads highest at a median of 1,700 KRW per share, and 1 of the 24 models we run sit above the 3,980 KRW price.

Bear case: the Earnings-Based group reads lowest at 403.87 KRW, and 23 of the 24 models stay below the price. Data coverage for this calculation is medium.

Scenario range: 688.98 KRW (bear) to 1,148 KRW (bull), the price of 3,980 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 49/100 (below-average quality), in the Technology sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

NanoenTekInc reported revenue of 38.1B KRW in FY2025 versus 35.8B KRW in FY2021, a compound +1.6%/yr. Reported net income was 1.6B KRW in FY2025, compounding −31.8%/yr from FY2021.

Key figures

Market cap 150B KRW (≈ $111M) Micro · P/E ratio 25.9 · P/S ratio 3.40 · EPS (TTM) 154.90 KRW · Net margin 13.3% · Return on equity 7.0% · Return on assets (EBIT) 2.3% (5-year average) · Operating margin 5.5%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 39 out of 100 (low confidence).

What moves the price

The share trades about 48% below its 52-week high and 31% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Technology peers we cover trades at −45% fair-value upside, at −77%, 039860 screens richer than that median.

Fair Value models

The price assumes far more growth than our models allow for, so the models scatter widely (319.02 KRW to 8,140 KRW). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear 688.98 KRW Fair Value 918.64 KRW Bull 1,148 KRW
Price 3,980 KRW · Downside -76.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (132.83 KRW per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF 754.36 KRW 968.09 KRW 1,247 KRW 82
Growth DCF 753.65 KRW 935.21 KRW 1,156 KRW 80
Owner Earnings 627.11 KRW 784.48 KRW 990.10 KRW 78
All 24 models by family
DCF Models
FCF DCF 754.36 KRW 968.09 KRW 1,247 KRW 82
Owner Earnings 627.11 KRW 784.48 KRW 990.10 KRW 78
5Y Revenue Exit 620.36 KRW 778.38 KRW 974.67 KRW 74
5Y EBITDA Exit 1,118 KRW 1,727 KRW 2,450 KRW 75
5Y P/E Exit 828.47 KRW 1,175 KRW 1,543 KRW 71
10Y Revenue Exit 666.47 KRW 814.53 KRW 1,007 KRW 68
10Y EBITDA Exit 951.77 KRW 1,394 KRW 2,004 KRW 68
10Y P/E Exit 789.32 KRW 1,057 KRW 1,390 KRW 65
Earnings-Based
Graham-Dodd 283.94 KRW 970.90 KRW 1,303 KRW 64
Lynch FV 223.31 KRW 319.02 KRW 414.72 KRW 61
PEG = 1.0 223.31 KRW 319.02 KRW 414.72 KRW 57
EPV 464.74 KRW 488.71 KRW 508.30 KRW 74
Multiples
P/E Multiple 688.98 KRW 918.64 KRW 1,148 KRW 63
P/S Multiple 532.39 KRW 709.86 KRW 887.32 KRW 58
P/B Multiple 6,105 KRW 8,140 KRW 10,175 KRW 55
EV/EBIT 642.89 KRW 766.60 KRW 890.31 KRW 66
EV/EBITDA 1,525 KRW 1,943 KRW 2,361 KRW 67
EV/Revenue 536.65 KRW 650.17 KRW 763.69 KRW 54
Asset-Based
NCAV (Graham) 1,122 KRW 1,700 KRW 2,125 KRW 54
Growth DCF
Growth DCF 753.65 KRW 935.21 KRW 1,156 KRW 80
Rev-Margin DCF 620.36 KRW 784.01 KRW 979.07 KRW 74
Economic Profit
Residual Income 1,323 KRW 1,386 KRW 1,525 KRW 71
ROIC Compounder 464.74 KRW 488.71 KRW 508.30 KRW 72
Growth Earnings
Growth-Adj P/E 585.91 KRW 837.01 KRW 1,088 KRW 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 49/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 27
How much profit the company makes from its sales and capital
Quality Growth 50
Are margins and returns getting better?
Cashflow 51
Do the profits arrive as real cash?
Financial strength 87
Debt, balance sheet and risk of trouble
Investment 40
Does it invest with discipline instead of growing at any price?
Low Volatility 43
How calm the share price moves, does not count
Price momentum 47
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 39
Distance to the 52-week high, does not count
New shares 49
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+25.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.3%
Start year 2020 (pandemic). Over 10 years: +4.4% a year
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.1%
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−25.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year−25.8%
Dividend (yield on the price)0.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.10% → 3%

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+32.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about +29.3% a year for the price.

039860 screens overvalued: fair value 77% below the price. Compare with Keysight Technologies, Inc →

Compare NanoenTekInc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Scientific & Technical Instruments · 160 stocks

Beats the industry median on 6/12 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 49 · Below median
Fair Value upside −76.9% · Bottom 25%
Profitability
Return on equity (12 months) 7.0% · Above median
Return on assets 1.6% · Below median
Net margin (12 months) 13.3% · Above median
Operating margin (12 months) 5.5% · Below median
Growth and dividend
Revenue growth (quarter YoY) 39.4% · Top 25%

Valuation Multiplesvs Scientific & Technical Instruments median · lower = cheaper

P/E (12 months) 25.9× · Cheaper than median
P/B 1.65× · Cheaper than median
P/S (12 months) 3.40× · Cheaper than median
Price / free cash flow (fiscal year) 73.9× · Priciest 25%
EV/EBITDA 25.5× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 0
FUTURE (revenue growth)100 · sector 47
PAST (return on equity)28 · sector 24
HEALTH (low debt)100 · sector 99
DIVIDEND (yield)0 · sector 20

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Scientific & Technical Instruments stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Garmin Ltd GRMN $285.57 $314.13 +10% vs 039860
Teledyne Technologies Incorporated TDY $618.60 $680.46 +10% vs 039860
MKS Inc MKSI $192.27 $199.16 +4% vs 039860
Cognex Corporation CGNX $47.78 $38.10 −20% vs 039860
Fortive Corporation FTV $65.37 $35.67 −45% vs 039860
Trimble Inc TRMB $54.11 $29.48 −46% vs 039860
Chroma ATE Inc 2360 1,250 TWD 607.12 TWD −51% vs 039860
Coherent Corp COHR $192.81 $92.93 −52% vs 039860
Keysight Technologies, Inc KEYS $272.13 $117.27 −57% vs 039860
AVIC Chengdu Aircraft Company 302132 ¥70.00 ¥12.60 −82% vs 039860

Explore undervalued stocks

More undervalued Technology stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

NanoenTekInc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "NanoenTekInc Fair Value". https://www.fairvalue-calculator.com/stock/039860

Frequently asked questions

Is NanoenTekInc (039860) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of 918.64 KRW versus a price of 3,980 KRW, about 77% lower (overvalued).
What is the fair value of 039860?
Our model-based fair value for NanoenTekInc is 918.64 KRW (as of Nov 8, 2026), built from audited fundamentals. The current price: 3,980 KRW.
What is the quality score of 039860?
NanoenTekInc has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for NanoenTekInc (039860)?
Our model-based price target is the fair value of 918.64 KRW (as of Nov 8, 2026) from 24 valuation models. Cautious scenario 688.98 KRW, optimistic scenario 1,148 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the NanoenTekInc stock forecast for 2026?
Our models put fair value at 918.64 KRW, about 77% lower versus a price of 3,980 KRW (overvalued). Cautious scenario 688.98 KRW, optimistic scenario 1,148 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of NanoenTekInc (039860)?
NanoenTekInc reported trailing-twelve-month revenue of about 44.2B KRW (latest available figure, as of Nov 8, 2026).
What growth is priced into NanoenTekInc (039860)?
For today's price to be fair in a discounted-cash-flow model, NanoenTekInc would have to grow free cash flow by +32.0 % per year for five years (discount rate 12.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +5.3 % per year. As of Nov 8, 2026.
What discount rate (WACC) does the fair value of 039860 use?
Our models discount NanoenTekInc at 12.1 %: a base by market capitalisation (micro), damped by beta 0.68, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For NanoenTekInc that is +32.0 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (12.1 %) and the same formula as our fair value.
How much growth has NanoenTekInc (039860) delivered so far?
Over the past 5 years revenue at NanoenTekInc grew +5.3 % a year. The price currently implies free-cash-flow growth of +32.0 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of NanoenTekInc (039860) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into NanoenTekInc (+32.0 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of NanoenTekInc (039860)?
The free-cash-flow yield on the price is 1.59 %: that much free cash flow NanoenTekInc produces per unit of market value. When it exceeds the discount rate of our models (12.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of NanoenTekInc (039860)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For NanoenTekInc it is 918.64 KRW per share (as of Nov 8, 2026), against a price of 3,980 KRW. It is the blended result of 24 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is NanoenTekInc stock overvalued or undervalued in 2026?
As of Nov 8, 2026, 039860 trades above its calculated fair value: price 3,980 KRW, fair value 918.64 KRW, a gap of about −77% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 039860?
No. The price is what the market pays today (3,980 KRW); the fair value is what the company's own numbers justify (918.64 KRW). For NanoenTekInc the two are 3,061 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is NanoenTekInc worth?
The market values NanoenTekInc at about 150B KRW (market capitalisation, as of Nov 8, 2026). Per share that is 3,980 KRW; our models calculate a fair value of 918.64 KRW per share.
What do the bullish and bearish scenarios say about 039860?
Our models span a range for NanoenTekInc: cautious scenario 688.98 KRW, base 918.64 KRW, optimistic 1,148 KRW per share (as of Nov 8, 2026, price 3,980 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 039860?
NanoenTekInc trades at a price-to-earnings ratio of 25.9 (as of Nov 8, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 918.64 KRW is built from several models across several years. Median P/E at fiscal year-end, 7 fiscal years (2018 to 2025), reported earnings: 33.7. Other multiples: P/B 1.7, P/S 3.4, EV/EBITDA 25.5.
How solid is the balance sheet of NanoenTekInc (039860)?
Balance-sheet figures for NanoenTekInc (as of Nov 8, 2026): return on equity 7.0%. They feed the Quality Score of 49/100, which measures business quality independently of the share price.
How far is 039860 from its 52-week high?
NanoenTekInc trades at 3,980 KRW, about 48% below its 52-week high of 7,670 KRW and 31% above the low of 3,030 KRW (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 918.64 KRW is for.
Which stocks are comparable to NanoenTekInc?
From the same area (Technology) we also value Keysight Technologies, Inc, Garmin Ltd, Coherent Corp, Teledyne Technologies Incorporated, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is NanoenTekInc stock attractive at the current price?
The data as of Nov 8, 2026: price 3,980 KRW, calculated fair value 918.64 KRW (−77%), Quality Score 49/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 039860 calculated?
We run NanoenTekInc through 24 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 918.64 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. NanoenTekInc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of NanoenTekInc (039860)?
The closing price on Nov 6, 2026 was 3,980 KRW. Our model-based fair value is 918.64 KRW, about 77% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with NanoenTekInc right now?
The price sits above even our optimistic bull case (1,148 KRW). The favourable scenario is already priced in. Weak quality (49/100) and above fair value at the same time, the margin of safety is missing on both counts.

Key figures of NanoenTekInc

How large is the market capitalisation of NanoenTekInc (039860)?
The market capitalisation of NanoenTekInc is 150B KRW (≈ $111M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of NanoenTekInc (039860)?
The price-to-sales ratio of NanoenTekInc is 3.40 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of NanoenTekInc (039860)?
Earnings per share at NanoenTekInc are 154.90 KRW (price ÷ EPS = P/E 25.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of NanoenTekInc (039860)?
The net margin of NanoenTekInc is 13.3% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of NanoenTekInc (039860)?
The return on equity (ROE) of NanoenTekInc is 7.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of NanoenTekInc (039860)?
On an EBIT basis the return on assets of NanoenTekInc is 2.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of NanoenTekInc (039860)?
The operating margin of NanoenTekInc is 5.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at NanoenTekInc (039860)?
Revenue at NanoenTekInc is growing +39.4% versus a year earlier (3y avg +2.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at NanoenTekInc (039860)?
Earnings per share at NanoenTekInc are growing +216% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed

Watch NanoenTekInc in the live analysis

One click puts NanoenTekInc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.